✦ LIBER ✦

Tamoxifen in the treatment of recurrent, advanced border line ovarian cancer: A single centre experience

✍ Scribed by C. Pisano; F.P. Magazzino; S. Greggi; S. Losito; R. Franco; G.S. Bruni; G. Facchini; S. Pignata

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Advanced (>second) line chemotherapy in

✍ Bruchim, Ilan; Jarchowsky-Dolberg, Osnat; Fishman, Ami 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 411 KB

Experience in a UK cancer centre of week

✍ M. Linch; F. Stavridi; J. Hook; Y. Barbachano; M. Gore; S.B. Kaye 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 199 KB

Cytoreduction combined with intraperiton

✍ F. Raspagliesi; S. Kusamura; J.C. Campos Torres; G.A. de Souza; A. Ditto; F. Zan 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 121 KB

A single centre's 10 year experience wit

✍ M.K. Lingam; D.S. Byrne; T. Aitchison; R.M. MacKie; A.J. McKay 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 662 KB

Treatment of recurrent ovarian cancer: a

✍ Don S Dizon; Jakob Dupont; Sibyl Anderson; Paul Sabbatini; Amanda Hummer; Carol 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Use of OvaRex(r) MAb-b43.13 as an immuno

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 161 KB